CE

CEimpact Appoints Eugene O'Donnell, J.D., as Vice President of Business Development and Ashlee Kleven Hayes, PharmD/MHA as Director of Business Marketing Strategy

Retrieved on: 
Friday, December 2, 2022

"We are delighted to welcome Eugene and Ashlee to the team," said Jen Moulton, President.

Key Points: 
  • "We are delighted to welcome Eugene and Ashlee to the team," said Jen Moulton, President.
  • They will both be an asset in supporting our growth and development."
  • O'Donnell arrives to CEimpact from Tabula Rasa Healthcare, where he most recently led business development and previously led expansion of tech-driven solutions that enabled pharmacists to provide clinical care activities.
  • O'Donnell previously served as CEO of the South Carolina Pharmacy Association and as the Executive Director of the Mississippi Pharmacy Association, where he advocated for pharmacists.

Celanese Corporation Lifts Force Majeure on Acetate Tow Products

Retrieved on: 
Thursday, December 1, 2022

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today confirmed it is lifting the remaining elements of the force majeure declared on May 11, 2022, which had still applied to acetate tow products.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today confirmed it is lifting the remaining elements of the force majeure declared on May 11, 2022, which had still applied to acetate tow products.
  • Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications.
  • Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation.
  • For more information about Celanese Corporation and its product offerings, visit www.celanese.com .

Haley & Aldrich and Cal Engineering & Geology Plan to Join Forces, Enhancing Geotechnical and Environmental Services for California Clients and Communities

Retrieved on: 
Thursday, December 1, 2022

Haley & Aldrich , a national environmental and engineering consultancy, announced today it is acquiring Cal Engineering & Geology (CE&G), a Northern California-based geotechnical engineering consultancy.

Key Points: 
  • Haley & Aldrich , a national environmental and engineering consultancy, announced today it is acquiring Cal Engineering & Geology (CE&G), a Northern California-based geotechnical engineering consultancy.
  • The acquisition unites Haley & Aldrichs nationwide environmental and geotechnical engineering expertise which includes extensive seismic and resilience engineering experience with CE&Gs regional geotechnical water infrastructure , transportation , and municipal practices.
  • This combination strengthens both firms abilities to help clients address pressing geotechnical, environmental, and sustainability issues, taking projects from planning through design and implementation.
  • Haley & Aldrich clients will benefit from CE&Gs in-depth California geotechnical and geo-civil expertise, as well as its cutting-edge remote sensing and applied-geographic information systems modeling.

Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022

Retrieved on: 
Thursday, December 1, 2022

Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022 being held on December 6 8, 2022.

Key Points: 
  • Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022 being held on December 6 8, 2022.
  • Dr. Chowdhury will be available for one-on-one investor meetings throughout the conference.
  • To attend the conference and request a meeting, register here:
    Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices.
  • Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA.

WISE Receives FDA Clearance for its WISE Cortical Strip Bringing Neuromonitoring to the Next Level

Retrieved on: 
Thursday, December 1, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221201005070/en/
    The WISE Cortical Strip is the first product receiving FDA clearance within the Companys WISEneuro Monitoring product family.
  • The FDA clearance follows the CE mark already received by the product in May 2021.
  • The WISE Cortical Strip performances have been successfully validated in a multicentric pre-market clinical study in Europe, the WIN study ( NCT03731455 ), that demonstrated safety, performance and usability of the product.
  • As a result, the WISE Cortical Strip is highly ergonomic and conformable to the brain surface.

Surgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciences

Retrieved on: 
Thursday, December 1, 2022

Surgical Innovation Associates (SIA) today announced that it entered into a definitive agreement to be acquired by Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company.

Key Points: 
  • Surgical Innovation Associates (SIA) today announced that it entered into a definitive agreement to be acquired by Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company.
  • The transaction is expected to close by the end of the year, subject to the satisfaction of customary conditions.
  • Today, there are no surgical matrices approved by the FDA specifically for use in implant-based breast reconstruction (IBBR) for mastectomy patients.
  • Integra is the only manufacturer so far to submit a premarket approval (PMA) application for this soft tissue support in IBBR.

Catheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals

Retrieved on: 
Thursday, December 1, 2022

Catheter Precisions lead product, VIVO (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time.

Key Points: 
  • Catheter Precisions lead product, VIVO (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time.
  • Additionally, Catheter Precision is working toward a commercial launch of a vessel closure device, currently planned for the first half of 2023.
  • Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias.
  • It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.

Volpara Health software used in largest image quality evaluation to date

Retrieved on: 
Wednesday, November 30, 2022

CHICAGO, Nov. 30, 2022 /PRNewswire/ -- At the 2022 Radiological Society of North America (RSNA) Annual Meeting, Peter R. Eby, MD, of Virginia Mason Medical Center presented the results of the largest mammographic image quality evaluation to date, titled "Reduction in technical repeat and recall rate after implementation of artificial intelligence driven quality improvement software."

Key Points: 
  • Volpara Analytics uses artificial intelligence (AI) to automatically and objectively measure the image quality of every mammogram image taken.
  • These improvements in objectively measured image quality indicators corresponded with technical repeats and recall rates decreasing from 0.77% ("baseline") to 0.17% ("current").
  • "Through the objective analysis of images, Volpara Analytics can help facilities improve image quality and reduce technical repeats and recalls."
  • Our AI-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression, and dose.

Endonovo Names Ira Weisberg President to Guide Global Medical Expansion

Retrieved on: 
Wednesday, November 30, 2022

Los Angeles, CA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today named Ira Weisberg as President and Chief Commercial Officer of its Medical Division.

Key Points: 
  • Los Angeles, CA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today named Ira Weisberg as President and Chief Commercial Officer of its Medical Division.
  • Throughout his career, Weisberg led negotiations and signed licensing deals for strategic acquisitions, distribution and development deals for multiple companies in the medical device and pharmaceutical industry.
  • His expertise is in developing strategies to guide emerging medical companies to advance revenue and enhance company diversity, developmental pipelines and geographic reach particularly in fast-growing emerging medical device and pharmaceutical markets.
  • Weisberg said in accepting the position: "I am thrilled to be joining the Endonovo team at such an exciting time.

Egg Medical Receives CE Mark for EggNest™ Radiation Protection System Release

Retrieved on: 
Wednesday, November 30, 2022

ARDEN HILLS, Minn., Nov. 30, 2022 /PRNewswire/ -- Egg Medical, Inc ., a medical device company commercializing technologies to reduce scatter radiation exposure during interventional angiographic procedures, today announced that it has achieved CE Mark for the EggNest XR radiation protection system.

Key Points: 
  • ARDEN HILLS, Minn., Nov. 30, 2022 /PRNewswire/ -- Egg Medical, Inc ., a medical device company commercializing technologies to reduce scatter radiation exposure during interventional angiographic procedures, today announced that it has achieved CE Mark for the EggNest XR radiation protection system.
  • With the CE Mark certification, Egg Medical will continue expansion into all markets recognizing the CE Mark.
  • "With CE mark approval of the EggNest platform, we are bringing this protection to more interventional teams worldwide."
  • The EggNest XR is a comprehensive, scatter radiation protection system fully integrated into the workflow of the modernCath Lab.